Skip to main content
. 2018 Nov 23;24:8439–8448. doi: 10.12659/MSM.910689

Figure 4.

Figure 4

Clinical outcome measurements after three months and six months of treatment with transcutaneous vagus nerve stimulation (tVNS). Results of the Self-Rating Anxiety Scale (SAS), the Self-Rating Depression Scale (SDS), and the Liverpool Seizure Severity Scale (LSSS), before (LSSS-1, SDS-1, SAS-1) and six months after treatment (LSSS-6, SDS-6, SAS-6) with transcutaneous vagus nerve stimulation (tVNS).